NCT01453075View on ClinicalTrials.gov

Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)

PHASE1CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

December 31, 2015

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG

Valacyclovir

Valacyclovir 1.5 mg po bid

DRUG

Placebo

Matching placebo twice daily

Trial Locations (1)

39216

G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS, Jackson

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

VA Office of Research and Development

FED

NCT01453075 - Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I) | Biotech Hunter | Biotech Hunter